Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation.
Several laboratories have resorted to flow-cytometric crossmatch (FCXM) in an effort to prevent hyperacute and accelerated renal allograft rejections. The currently employed FCXM has problems with both false-positive and -negative reactions, largely as a result of irrelevant IgG binding to Fc IgG receptors. In 1980, we circumvented this problem by digesting Fc IgG receptors with pronase, and demonstrated that, with immunofluorescence microscopy (IF), detection of IgG anti-HLA antibodies was highly sensitive and specific. In 1995, we introduced the pronase technique to FCXM and showed that this enzyme did not decrease HLA expression. We present herein a prospective study at our institution to determine whether FCXM using pronase-digested (PD) lymphocytes is as sensitive and more specific than FCXM with undigested (UD) lymphocytes when compared with the highly sensitive and specific IF assay. In analyzing the 186 donor-specific pre-renal-transplant crossmatches, we found that PD FCXM was as sensitive and specific as IF and was able to detect weak IgG anti-HLA antibodies that bound to B cells. Fourteen of these patients would have been denied transplants if one were to have relied on UD FCXM. The data clearly indicate that PD FCXM can reliably be used to detect weak IgG anti-HLA antibodies before renal transplantation.
Lobo
Peter I
PI
Division of Nephrology, Department of Internal Medicine, University of Virginia, P.O. Box 800133, Charlottesville, VA 22098, USA. pil@virginia.edu
Isaacs
Ross B
RB
Spencer
Clint E
CE
Pruett
Timothy L
TL
Sanfey
Hillary A
HA
Sawyer
Robert G
RG
McCullough
Christopher
C
D000906:Antibodies / Q000032:analysis; D005455:Fluorescent Antibody Technique; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing / Q000379:methods*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D016030:Kidney Transplantation; D008214:Lymphocytes / Q000187:drug effects*; D011402:Pronase / Q000494:pharmacology*; D011446:Prospective Studies; D012680:Sensitivity and Specificity
D000906:Antibodies; D006680:HLA Antigens; D007074:Immunoglobulin G; D011402:Pronase